Analyst Ratings for Regeneron Pharma (regn)
regn Rating Summary
regn Price Target Summary
- Highest: $315.00 (Brean Capital)
- Lowest: $60.00 (Needham & Company)
- Average: $163.53
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$163.53 (-39.8%)
Avg. $ Target:
$163.53 (-39.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/17/2013 | UBS | New Coverage | Neutral (N/A) |
290.00 (N/A) |
264.66 | 271.53 | 2.6% | Details |
| 5/3/2013 | Brean Capital | Upgrade | Buy (Hold) |
315.00 (N/A) |
248.63 | 271.53 | 9.21% | Details |
| 5/2/2013 | JMP Securities | Upgrade | Market Outperform (Market Perform) |
N/A (N/A) |
237.29 | 271.53 | 14.43% | Details |
| 2/28/2013 | Barclays | New Coverage | Overweight (N/A) |
194.00 (N/A) |
164.80 | 271.53 | 64.76% | Details |
| 1/15/2013 | Jefferies | Downgrade | Hold (Buy) |
179.00 (179.00) |
179.40 | 271.53 | 51.35% | Details |
| 11/13/2012 | Credit Suisse | New Coverage | Outperform (N/A) |
187.00 (N/A) |
144.90 | 271.53 | 87.39% | Details |
| 8/7/2012 | Lazard Capital | New Coverage | Neutral (N/A) |
N/A (N/A) |
137.45 | 271.53 | 97.55% | Details |
| 7/25/2012 | BMO Capital | Upgrade | Outperform (Market Perform) |
158.00 (143.00) |
121.44 | 271.53 | 123.59% | Details |
| 4/2/2012 | Goldman Sachs » Updated 4/9/2013 |
New Coverage | Buy (N/A) |
215.00 (196.00) |
116.62 | 271.53 | 132.83% | Details |
| 2/6/2012 | Piper Jaffray | Downgrade | Neutral (N/A) |
81.00 (N/A) |
4.14 | 271.53 | 6458.7% | Details |
| 2/3/2012 | ThinkEquity | New Coverage | Buy (N/A) |
120.00 (N/A) |
95.01 | 271.53 | 185.79% | Details |
| 1/30/2012 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
85.54 | 271.53 | 217.43% | Details |
| 1/17/2012 | Roth Capital | Downgrade | Neutral (N/A) |
78.00 (N/A) |
78.92 | 271.53 | 244.06% | Details |
| 1/10/2012 | Baird » Updated 1/15/2013 |
Upgrade | Outperform (N/A) |
205.00 (176.00) |
65.48 | 271.53 | 314.68% | Details |
| 10/26/2011 | Leerink Swann » Updated 4/3/2013 |
Upgrade | Outperform (N/A) |
190.00 (185.00) |
57.09 | 271.53 | 375.62% | Details |
